Please note that any drug repurposing ideas or suggestions submitted through our website are considered non-confidential and non-proprietary. By submitting your ideas, you agree that these submissions do not contain intellectual property that you or a third party own or control. Every Cure does not claim ownership of your submissions; however, by providing your ideas, you grant us an unrestricted, worldwide, royalty-free license to use, reproduce, and distribute the ideas for the purpose of research, analysis, and furtherance of our mission. We appreciate your contributions to our efforts in advancing healthcare innovation.

Expert Insight Spotlight:

Dr. Luke Chen, MD expert insights were instrumental in helping to find a cure to Albert, a 50-year-old Castleman patient who exhausted all known treatments. Albert was prescribed adalimumab by Dr. Chen after consultation with Dr. Fajgenbaum and his team from Every Cure, who had identified the potential benefit of this medication using an AI-guided proteomics approach.